Many experts agree that, in a best-case scenario, widespread access to a vaccine won’t happen until mid-2021.
This distorted idea has emerged at the intersection between neoliberalism and fascism, says scholar Angela Mitropoulos.
Following the FDA recommendations would all but preclude any emergency clearance for a vaccine before Election Day.
Even if Pfizer’s vaccine trial yields results by November 3, the FDA review would still take weeks to complete.
Moncef Slaoui owns $10 million in stock of a company working with his team to develop a vaccine.
Trump claimed that he trusts for-profit pharmaceutical corporations to conduct adequate safety testing.
The senator’s remarks came hours after Trump suggested a vaccine could be put to market “before a very special day.”
Shunning the international community in vaccine development and distribution is emblematic of Trump’s America.
Companies are receiving federal grants without guaranteeing they will make the vaccine affordable for all.
Insiders from at least 11 companies working on COVID research have sold shares worth more than $1 billion since March.